How much does it cost to visit Sunlenca for a year?

Lenapavir sodium/Sunlenca (Sunlenca) is a new long-acting HIV-1 capsid inhibitor developed by Gilead Sciences. Its research and development background is to solve two long-standing problems: first, the presence of multi-drug-resistant HIV (AIDS) strains in some patients, resulting in ineffective conventional antiretroviral treatment; second, most traditional drugs need to be taken daily, and lack of patient compliance can easily affect the efficacy. The launch of Sunlenca has brought new treatment options to multi-drug-resistant patients. At the same time, because of its characteristics of being injected once every six months, it is regarded as an important breakthrough in the anti-AIDS field.

From a mechanism perspective, lenapavir sodium interferes with multiple stages of virus replication by targetingHIV capsid protein, including virus entry into host cells, nucleic acid integration, assembly and release. It is different from previous drugs that only act on a single replication link, so it can show unique value in drug-resistant people. This multi-site intervention model greatly enhances the clinical application prospects of the drug.

In actual use, the administration methods of lenapavir sodium can be divided into oral tablets and subcutaneous injections. The initial phase usually requires combined oral tablets and injections to establish effective blood concentration; then the maintenance phase begins, with only two injections every six months to complete the treatment cycle. This model not only reduces the pressure on patients to take daily medications, but also reduces the risk of treatment failure due to missed doses.

Regarding cost, lenapavir sodium is a high-priced drug due to its innovative mechanism and long-acting characteristics. Taking the overseas market as an example, the injection specification is 463.5mg/1.5ml2, and the price of a box is about 100,000 yuan; the tablet specification is 300mg5 tablets, and the market price is around 50,000 yuan. According to the recommended initial medication regimen, a combination of oral and injection is usually required in the first year, and the comprehensive cost may reach about 200,000 yuan. It should be noted that this price is not completely fixed and will be affected by regional differences, medical insurance coverage and supply channels.

Reference materials:https://www.drugs.com/sunlenca.html